European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary ...

Jeff Bolle was a larger than life figure roaming the sidelines of Marquette University High School football games. A standout ...

He conceived many of the techniques and tools that have revolutionized minimally invasive operations and procedures.

Even after the diagnosis Ms Edwards said her mother was told her procedure was a routine one with very rare issues ...

Many people worry that passing gallstones is linked to an increased risk of bile duct cancer due to inflammation and ...

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its ...

Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly ...

Obeticholic acid was given accelerated approval by the FDA in May 2016 as a second-line treatment for PBC patients not ...

Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, ...

Cholangiocarcinoma is classically described as an irregular narrowing of the bile duct with shouldered scalloped margins. The stricture usually causes a high-grade or complete obstruction with ...

胆管（bile ducts，BD）在肝脏门静脉周围特异性发育，负责将肝细胞分泌的胆汁输送到肠道。胆管细胞是肝内胆管（intrahepatic bile ...